{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T10:15:15Z","timestamp":1784110515247,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002877"],"award-info":[{"award-number":["82002877"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U19A2005"],"award-info":[{"award-number":["U19A2005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270986"],"award-info":[{"award-number":["82270986"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Dyskeratosis congenita (DC) is a rare and fatal disease, presenting with a classic triad of skin pigmentation, nail dystrophy and oral leukoplakia. However, diagnosing DC is challenging based solely on the protean manifestations and multisystemic involvement. Therefore, it is urgent to identify an early feature facilitating initial suspicion of DC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In this study, we enrolled a cohort of six male children diagnosed with DC, all of whom exhibited erosions or ulcers on the tongue, while five of them did not display the complete classic triad. Strikingly, oral erosions or ulcers have never been included in any existing clinical diagnostic criteria for DC. Through a retrospective analysis, we further demonstrated that extensive and persistent tongue ulceration emerges as an early and practicable clinical marker, provoking suspicion of DC even in the absence of the classic triad.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our findings challenge prevailing diagnostic criteria and advocates for an expanded consideration of tongue ulceration as a primary and indicative manifestation of DC, thereby affording a strategic advantage for early detection and intervention of this lethal disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03721-4","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T18:54:02Z","timestamp":1745261642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Extensive and persistent tongue ulceration is an early character of dyskeratosis congenita"],"prefix":"10.1186","volume":"20","author":[{"given":"Xuefeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanxin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2621-5770","authenticated-orcid":false,"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"3721_CR1","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/S0140-6736(01)07040-4","volume":"358","author":"I Dokal","year":"2001","unstructured":"Dokal I. A disease of premature ageing. Lancet. 2001;358:S27.","journal-title":"Lancet"},{"issue":"4","key":"3721_CR2","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","volume":"110","author":"I Dokal","year":"2000","unstructured":"Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110(4):768\u201379.","journal-title":"Br J Haematol"},{"key":"3721_CR3","doi-asserted-by":"crossref","unstructured":"Dokal I. Dyskeratosis congenita. Stiehm\u2019s Immune Deficiencies. 2014:267\u2013\u200980.","DOI":"10.1016\/B978-0-12-405546-9.00011-X"},{"issue":"9396","key":"3721_CR4","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/S0140-6736(03)14797-6","volume":"362","author":"PF Fogarty","year":"2003","unstructured":"Fogarty PF, Yamaguchi H, Wiestner A, Baerlocher GM, Sloand E, Zeng WS, et al. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet. 2003;362(9396):1628\u201330.","journal-title":"Lancet"},{"issue":"2","key":"3721_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.hoc.2009.01.003","volume":"23","author":"SA Savage","year":"2009","unstructured":"Savage SA, Alter BP. Dyskeratosis congenita. Hematol Oncol Clin N Am. 2009;23(2):215\u201331.","journal-title":"Hematol Oncol Clin N Am"},{"issue":"3","key":"3721_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1532\/IJH97.05067","volume":"82","author":"AJ Walne","year":"2005","unstructured":"Walne AJ, Marrone A, Dokal I. Dyskeratosis congenita: a disorder of defective telomere maintenance? Int J Hematol. 2005;82(3):184\u20139.","journal-title":"Int J Hematol"},{"key":"3721_CR7","doi-asserted-by":"crossref","unstructured":"Dokal I, Vulliamy T, Mason P, Bessler M. Clinical utility gene card for: dyskeratosis congenita - update 2015. Eur J Hum Genet. 2015;23(4).","DOI":"10.1038\/ejhg.2014.170"},{"issue":"12","key":"3721_CR8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00431-003-1317-5","volume":"162","author":"Y Sznajer","year":"2003","unstructured":"Sznajer Y, Baumann C, David A, Journel H, Lacombe D, Perel Y, et al. Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome). Eur J Pediatr. 2003;162(12):863\u20137.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"3721_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.gene.2014.06.011","volume":"546","author":"BC Lim","year":"2014","unstructured":"Lim BC, Yoo SK, Lee S, Shin JY, Hwang H, Chae JH, et al. Hoyeraal-Hreidarsson syndrome with a DKC1 mutation identified by whole-exome sequencing. Gene. 2014;546(2):425\u20139.","journal-title":"Gene"},{"issue":"2","key":"3721_CR10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1182\/blood-2006-07-035089","volume":"109","author":"ZT Xin","year":"2007","unstructured":"Xin ZT, Beauchamp AD, Calado RT, Bradford JW, Regal JA, Shenoy A, et al. Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood. 2007;109(2):524\u201332.","journal-title":"Blood"},{"issue":"7","key":"3721_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.6002\/ect.2020.0073","volume":"20","author":"M Alebrahim","year":"2022","unstructured":"Alebrahim M, Akateh C, Arnold CA, Benissan-Messan D, Chavez JA, Singh N, et al. Liver transplant for management of hepatic complications of dyskeratosis congenita: A case report. Exp Clin Transpl. 2022;20(7):702\u20135.","journal-title":"Exp Clin Transpl"},{"issue":"12","key":"3721_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/GIM.0b013e3181f415b5","volume":"12","author":"SA Savage","year":"2010","unstructured":"Savage SA, Bertuch AA. The genetics and clinical manifestations of telomere biology disorders. Genet Med. 2010;12(12):753\u201364.","journal-title":"Genet Med"},{"issue":"3","key":"3721_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.blre.2010.03.002","volume":"24","author":"A Shimamura","year":"2010","unstructured":"Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010;24(3):101\u201322.","journal-title":"Blood Rev"},{"key":"3721_CR14","first-page":"219","volume":"5","author":"F Zinsser","year":"1906","unstructured":"Zinsser F. Atropha cutis reticularis pigmentation, dystrophia ungiumet leukoplakia Oris. Ikonogr Dermatol (Hyoto). 1906;5:219\u201323.","journal-title":"Ikonogr Dermatol (Hyoto)"},{"key":"3721_CR15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archderm.1926.02370170087012","volume":"13","author":"M Engman","year":"1926","unstructured":"Engman M. A unique case of reticular pigmentation of the skin with atrophy. Arch Derm Syph. 1926;13:685\u20137.","journal-title":"Arch Derm Syph"},{"issue":"1","key":"3721_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archderm.1930.01440070079008","volume":"21","author":"H Cole","year":"1930","unstructured":"Cole H, Rauschkolb J, Toomey J. Dyskeratosis congenita with pigmentation, dystrophia Unguis and leukokeratosis Oris. Archives Dermatology Syphilology. 1930;21(1):71\u201395.","journal-title":"Archives Dermatology Syphilology"},{"issue":"15","key":"3721_CR17","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1056\/NEJMicm1613081","volume":"376","author":"DA Kelmenson","year":"2017","unstructured":"Kelmenson DA, Hanley M. Dyskeratosis congenita. N Engl J Med. 2017;376(15):1460.","journal-title":"N Engl J Med"},{"issue":"27","key":"3721_CR18","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1056\/NEJMcpc1408595","volume":"373","author":"JE Walter","year":"2015","unstructured":"Walter JE, Armanios M, Shah U, Friedmann AM, Spitzer T, Sharatz SM, et al. Case records of the massachusetts general hospital. Case 41-2015. A 14-Year-Old Boy with immune and liver abnormalities. N Engl J Med. 2015;373(27):2664\u201376.","journal-title":"N Engl J Med"},{"issue":"5","key":"3721_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1651-2227.1988.tb10751.x","volume":"77","author":"S Hreidarsson","year":"1988","unstructured":"Hreidarsson S, Kristjansson K, Johannesson G, Johannsson J. A syndrome of progressive pancytopenia with microcephaly, cerebellar hypoplasia and growth failure. Acta Paediatr. 1988;77(5):773\u20135.","journal-title":"Acta Paediatr"},{"issue":"3","key":"3721_CR20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/odi.13035","volume":"25","author":"X Zhang","year":"2019","unstructured":"Zhang X, Wang J, Wang F, Jin X, Zhou Y, Dan H, et al. Extensive erosion instead of leukoplakia can be the oral manifestation of dyskeratosis congenita. Oral Dis. 2019;25(3):919\u201321.","journal-title":"Oral Dis"},{"issue":"9","key":"3721_CR21","first-page":"943","volume":"18","author":"MM AlSabbagh","year":"2020","unstructured":"AlSabbagh MM. Dyskeratosis congenita: a literature review. J Dtsch Dermatol Ges. 2020;18(9):943\u201367.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"10","key":"3721_CR22","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1111\/ijd.16215","volume":"61","author":"MMS Nico","year":"2022","unstructured":"Nico MMS, Yendo TM, Lourenco SV. Understanding oral mucosal lesions in dyskeratosis congenita: from interface inflammation to squamous cell carcinoma, an observational report. Int J Dermatol. 2022;61(10):e366\u20138.","journal-title":"Int J Dermatol"},{"issue":"7286","key":"3721_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nature08792","volume":"464","author":"S Agarwal","year":"2010","unstructured":"Agarwal S, Loh Y-H, McLoughlin EM, Huang J, Park I-H, Miller JD, et al. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature. 2010;464(7286):292\u20136.","journal-title":"Nature"},{"issue":"7351","key":"3721_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature10084","volume":"474","author":"LF Batista","year":"2011","unstructured":"Batista LF, Pech MF, Zhong FL, Nguyen HN, Xie KT, Zaug AJ, et al. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature. 2011;474(7351):399\u2013402.","journal-title":"Nature"},{"issue":"12","key":"3721_CR25","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1182\/blood.2021013523","volume":"139","author":"MR Niewisch","year":"2022","unstructured":"Niewisch MR, Giri N, McReynolds LJ, Alsaggaf R, Bhala S, Alter BP, et al. Disease progression and clinical outcomes in telomere biology disorders. Blood. 2022;139(12):1807\u201319.","journal-title":"Blood"},{"issue":"6761","key":"3721_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/990141","volume":"402","author":"JR Mitchell","year":"1999","unstructured":"Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402(6761):551\u20135.","journal-title":"Nature"},{"issue":"3","key":"3721_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1586\/ehm.13.23","volume":"6","author":"BJ Ballew","year":"2013","unstructured":"Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol. 2013;6(3):327\u201337.","journal-title":"Expert Rev Hematol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03721-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03721-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03721-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T18:54:07Z","timestamp":1745261647000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03721-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3721"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03721-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. All human work was approved by Institutional Review Board approval of the West China Hospital of Stomatology. Written informed consent was obtained from all included patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}